The main aim of this study is to characterise the humanistic burden of bladder pain syndrome (BPS) on patients within the United Kingdom and to estimate the key healthcare resource usage and cost of treating these patients.
Method:
An online survey was administered through two charities. Respondents were asked questions on BPS diagnosis, socio-demographics and health-related quality of life using the O’Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI), the Pelvic Pain and Urinary/Frequency (PUF) and the EQ-5D questionnaires. Healthcare resource and therapy use, for the previous 6 months, were recorded and used to calculate economic burden.
Results:
A total of 252 patients completed the survey. Mean ICSI ICPI scores were 12.6 and 11.0, respectively, indicating severe symptoms. Mean PUF score was 21.2, indicating poor health status and a high number of BPS-related symptoms and problems. Mean EQ-5D utility score was 0.541. In the previous 6 months, 172 (68%) saw their general practitioner (GP) and 80 (32%) a primary care nurse, and 165 (65%) had one or more outpatient visits, due to their BPS.
Conclusion:
This survey adds to our current understanding of BPS in the United Kingdom, highlighting that patients with BPS have poor health-related quality of life and incur high resource use.
Van de MerweJPNordlingJBoucheloucheP, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: An ESSIC proposal. Eur Urol2008; 53(1): 60–67.
PatnaikSSLaganàASVitaleSG, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet2017; 295(6): 1341–1359.
4.
HakimiZHoubiersJPedersiniR, et al. The burden of bladder pain in five European countries: A cross-sectional study. Urology2017; 99: 84–91.
5.
BerrySHElliottMNSuttorpM, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol2011; 186(2): 540–544.
6.
ClemensJQEricksonDRVarelaNP, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol2022; 208(1): 34–42.
7.
AcarÖTarcanT. Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome. J Turk Ger Gynecol Assoc2019; 20(2): 117–122.
8.
WatanabeDAkiyamaYNiimiA, et al. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations. Low Urin Tract Symptoms2021; 13(1): 139–143.
9.
KoKJChoWJLeeYS, et al. Comparison of the efficacy between transurethral coagulation and transurethral resection of hunner lesion in interstitial cystitis/bladder pain syndrome patients: A prospective randomized controlled trial. Eur Urol2020; 77(5): 644–651.
10.
JiangTZhouXChenZ, et al. Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome. BMC Urol2020; 20(1): 36.
11.
KoziolJAClarkDCGittesRF, et al. The natural history of interstitial cystitis: A survey of 374 patients. J Urol1993; 149(3): 465–469.
12.
TroxelWMBoothMBuysseDJ, et al. Sleep disturbances and nocturnal symptoms: Relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome. J Clin Sleep Med2014; 10(12): 1331–1337.
13.
VasudevanVMoldwinR.Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome. Asian J Urol2017; 4(1): 50–54.
14.
TincelloDGWalkerAC.Interstitial cystitis in the UK: Results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol2005; 118(1): 91–95.
15.
LinKBWuMPLinYK, et al. Lifestyle and behavioral modifications made by patients with interstitial cystitis. Sci Rep2021; 11(1): 3055.
16.
Van HoutBJanssenMFFengYS, et al. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health2012; 15(5): 708–715.
17.
WuCYChenIHTongYC.Long-term treatment outcomes in patients with interstitial cystitis/painful bladder syndrome: 10-year experience in NCKUH. Urol Sci2013; 24(1): 10–13.
18.
CoxAGoldaNNadeauG, et al. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J2016; 10(5–6): E136–E155.
BarofskyI.Can quality or quality-of-life be defined?Qual Life Res2012; 21: 625–631.
22.
SairanenJLeppilahtiMTammelaTL, et al. Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it. Scand J Urol Nephrol2009; 43(3): 212–219.
23.
O’LearyMPSantGRFowlerFJ, et al. The interstitial cystitis symptom index and problem index. Urology1997; 49(5A suppl.): 58–63.
24.
YoshimuraNUnoTSasakiM, et al. The O’Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution. Int J Urol2022; 29(4): 289–296.
25.
ParsonsCLDellJStanfordEJ, et al. Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology2002; 60(4): 573–578.
26.
MinagliaSOzelBNguyenJN, et al. Validation of Spanish version of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Urology2005; 65(4): 664–669.
27.
MichaelYLKawachiIStampferMJ, et al. Quality of life among women with interstitial cystitis. J Urol2000; 164(2): 423–427.
28.
El KhoudarySRTalbottEOBrombergerJT, et al. Severity of interstitial cystitis symptoms and quality of life in female patients. J Womens Health2009; 18(9): 1361–1368.
GallowayJEdwardsJBhagatS, et al. Direct healthcare resource utilisation, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: An observational study. BMC Musculoskelet Disord2021; 22(1): 277.
31.
Collado-MateoDChenGGarcia-GordilloMA, et al. Fibromyalgia and quality of life: Mapping the revised fibromyalgia impact questionnaire to the preference-based instruments. Health Qual Life Outcomes2017; 15(1): 114.
32.
ZhouTGuanHWangL, et al. Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: A systematic review. Front Public Health2021; 9: 675523.
HsiehKLChinHYLoTS, et al. Interstitial cystitis/bladder pain syndrome patient is associated with subsequent increased risks of outpatient visits and hospitalizations: A population-based study. PLoS One2021; 16(9): e0256800.
41.
ChungSDLiuSPLiHC, et al. Health care service utilization among patients with bladder pain syndrome/interstitial cystitis in a single payer healthcare system. PLoS One2014; 9(1): e87522.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
